AD-O53.2-novel biological anticancer therapeutic agent with a dual mechanism of action

被引：0
|
作者：
Poleszak, K. [1 ]
Pieczykolan, J. [1 ]
Pawlak, S. [1 ]
Zerek, B. [1 ]
Rozga, P. [1 ]
Teska-Kaminska, M. [1 ]
Galazka, M. [1 ]
Szymanik, M. [1 ]
Jaworski, A. [1 ]
Pieczykolan, A. [1 ]
Bukato, K. [1 ]
Strozek, W. [1 ]
机构：
[1] Adamed Sp Zoo, Drug Discovery, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70645-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
519
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [41] Novel dual mechanism of action reported for CP-248
    不详
    DRUG NEWS & PERSPECTIVES, 2002, 15 (06) : 388 - 388
  • [42] Investigation of the biological activity and mechanism of action of novel heterocyclic imines
    Segrist, Elisha
    Delawder, Abby
    Liles, Kevin
    Dopp, Daniel
    Manpadi, Madhuri
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [43] NS2710: A novel anxiolytic with a dual mechanism of action
    Mirza, NR
    Watjen, F
    Hartz, BP
    Teuber, L
    Nielsen, EO
    Mathiasen, LI
    Johansen, TH
    Jensen, LH
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S24 - S24
  • [44] Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent
    Zhou, Yun
    Yu, Yijun
    Lv, He
    Zhang, Hao
    Liang, Tianzi
    Zhou, Guoer
    Huang, Liping
    Tian, Yizhou
    Liang, Wenqing
    FOOD AND CHEMICAL TOXICOLOGY, 2022, 168
  • [45] Synthesis, characterization and biological assessment of a novel hydrazone as potential anticancer agent and enzyme inhibitor
    Noma, Samir Abbas Ali
    Erzengin, Mahmut
    Tunc, Tuncay
    Balcioglu, Sevgi
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1205
  • [46] Design, synthesis, and biological evaluation of a novel anticancer agent ON 015640 with tubulin depolymerizing activity
    Mallireddigari, Muralidhar R.
    Pallela, Venkat R.
    Hoffman, Benjamin S.
    Bharathi, Vijaya
    Akula, Balaiah
    Cosenza, Stephen C.
    Reddy, E. Premkumar
    Reddy, M. V. Ramana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [47] Discovery of a novel anticancer benzopyrane derivative with an effective multitarget mechanism of action.
    Zaher, Dana
    Ramadan, Wafaa
    El-Awady, Raafat
    Omar, Hany
    Hersi, Fatema
    Srinivasulu, Vunnam
    Al-Tel, Taleb
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Molecular mechanism of asthma and its novel molecular target therapeutic agent
    Suraya, Ratoe
    Nagano, Tatsuya
    Katsurada, Masahiro
    Sekiya, Reina
    Kobayashi, Kazuyuki
    Nishimura, Yoshihiro
    RESPIRATORY INVESTIGATION, 2021, 59 (03) : 291 - 301
  • [49] A Concise Review of Synthetic Strategy, Mechanism of Action, and SAR Studies of Phthalazine Derivatives as Anticancer Agent
    Arya, Girish Chandra
    Sharma, Rajiv
    Mehla, Shefali
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (14) : 2838 - 2852
  • [50] The triple action of leflunomide: a novel therapeutic mechanism of action in the treatment of inflammatory skin diseases
    Rikken, G.
    Schalkwijk, J.
    Van den Bogaard, E. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E41 - E41
12345